Pricing Log in Create free account

Celularity, Inc. (CELU) vs Veru Inc. (VERU)

Celularity, Inc. and Veru Inc. are both Biotechnology companies. Celularity, Inc. and Veru Inc. are of similar size ($43.2M and $41.6M). Veru Inc. grew revenue faster over the last twelve months: 52.7% against −62.8%. Veru Inc. has the higher net margin (0.00% vs −375.9%) and the higher return on invested capital (−464.0% vs −695.7%). Across the 17 metrics below, Veru Inc. leads on 11 and Celularity, Inc. on 6.

Valuation

Metric CELU VERU Biotechnology median
P/E n/m n/m 8.50
P/S 1.92 2.13 9.71
P/B n/m 1.87 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.06 1.22 9.21
Earnings yield (217.31%) (25.24%) (33.15%)
Free cash flow yield (24.70%) (49.13%) (25.50%)

Profitability

Metric CELU VERU Biotechnology median
Gross margin 5.26% 32.44% 65.16%
Operating margin (321.32%) 0.00% 0.00%
Net margin (375.89%) 0.00% 0.00%
Free cash flow margin (46.46%) 0.00% 0.00%
Return on equity 349.83% (62.25%) (56.36%)
Return on assets (62.45%) (42.29%) (48.04%)
Return on invested capital (695.71%) (464.03%) 0.00%

Growth

Metric CELU VERU Biotechnology median
Revenue growth (TTM) (62.78%) 52.69% 6.02%
EPS growth (last fiscal year) (35.71%) 44.64% 30.26%
Revenue growth, 5-year CAGR 13.21% (11.89%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELU VERU Biotechnology median
Debt to equity (1.17) 0.00 0.00
Current ratio 0.09 4.42 4.72
Net debt to EBITDA (0.77) 0.74 0.96

Dividend

Metric CELU VERU Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CELU VERU Biotechnology median
Market cap 43.16m 41.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack